A Signature of Pre-Operative Biomarkers of Cellular Senescence to Predict Risk of Cardiac and Kidney Adverse Events after Cardiac Surgery. Cardiology and Cardiovascular Medicine, v. 8, n. 3, p. 267–274, 26 Jun.2024.